SOX9 and neoplasm: Besides, a truncated version of SOX9 devoid of transactivation domain as a result of retention of the second intron called MiniSOX9 has been discovered in human tumor samples of CRC; this version is expressed at high levels in CRC but it is undetectable in the surrounding healthy tissue.